• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于壳聚糖和蒙脱石的 pH 敏感纳米复合微球具有体外降低突释效应。

A pH-sensitive nanocomposite microsphere based on chitosan and montmorillonite with in vitro reduction of the burst release effect.

机构信息

Center of Eco-material and Green Chemistry, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou, PR China.

出版信息

Drug Dev Ind Pharm. 2010 Sep;36(9):1106-14. doi: 10.3109/03639041003677798.

DOI:10.3109/03639041003677798
PMID:20334540
Abstract

OBJECTIVE

The aim of this study was to prepare pH-sensitive ofloxacin (OFL)/montmorillonite (MMT)/chitosan (CTS) nanocomposite microspheres that improve the burst release effect of the drug by the solution intercalation technique and emulsification cross-linking techniques.

METHODS

First, OFL/MMT hybrids were prepared through the solution intercalation technique. Then, OFL/MMT-intercalated OFL/MMT/CTS nanocomposite microspheres were obtained through emulsification cross-linking technology. The intercalated nanocomposite was confirmed by Fourier-transform infrared spectroscopy and X-ray diffraction. Finally, in vitro release of OFL from the microspheres was performed in simulated gastric fluids and simulated intestinal fluids. The effect of MMT content on drug encapsulation efficiency and the drug release of the nanocomposite microspheres were investigated.

RESULTS

The results showed that the release rate of OFL from the nanocomposite microspheres at pH 7.4 was higher than that at pH 1.2. Compared with pure CTS microspheres, the incorporation of certain amount of MMT in the nanocomposite microspheres can enhance the drug encapsulation efficiency and reduce the burst release.

CONCLUSION

A sustained release particulate system can be obtained by incorporating MMT into the nanocomposite microspheres and can improve the burst release effect of the drug.

摘要

目的

本研究旨在制备 pH 敏感的氧氟沙星(OFL)/蒙脱石(MMT)/壳聚糖(CTS)纳米复合微球,通过溶液插层技术和乳化交联技术改善药物的爆发释放效果。

方法

首先,通过溶液插层技术制备 OFL/MMT 杂化物。然后,通过乳化交联技术获得 OFL/MMT 插层-OFL/MMT/CTS 纳米复合微球。通过傅里叶变换红外光谱和 X 射线衍射确认插层纳米复合材料。最后,在模拟胃液和模拟肠液中进行微球中 OFL 的体外释放。考察了 MMT 含量对纳米复合微球药物包封率和药物释放的影响。

结果

结果表明,纳米复合微球在 pH 7.4 时的释放速率高于 pH 1.2 时的释放速率。与纯 CTS 微球相比,纳米复合微球中加入一定量的 MMT 可以提高药物包封率,降低突释。

结论

通过将 MMT 掺入纳米复合微球中,可以获得缓释颗粒系统,从而改善药物的爆发释放效果。

相似文献

1
A pH-sensitive nanocomposite microsphere based on chitosan and montmorillonite with in vitro reduction of the burst release effect.基于壳聚糖和蒙脱石的 pH 敏感纳米复合微球具有体外降低突释效应。
Drug Dev Ind Pharm. 2010 Sep;36(9):1106-14. doi: 10.3109/03639041003677798.
2
Adsorption characteristics of Congo Red onto the chitosan/montmorillonite nanocomposite.刚果红在壳聚糖/蒙脱石纳米复合材料上的吸附特性
J Hazard Mater. 2007 Aug 25;147(3):979-85. doi: 10.1016/j.jhazmat.2007.01.145. Epub 2007 Feb 9.
3
Drug release behavior of chitosan-montmorillonite nanocomposite hydrogels following electrostimulation.壳聚糖-蒙脱石纳米复合水凝胶在电刺激后的药物释放行为
Acta Biomater. 2008 Jul;4(4):1038-45. doi: 10.1016/j.actbio.2008.01.012. Epub 2008 Feb 8.
4
The design of biodegradable ofloxacin-based core-shell microspheres: influence of the formulation parameters on in vitro characterization.基于可生物降解的氧氟沙星的核壳型微球的设计:配方参数对体外特性的影响。
Pharm Dev Technol. 2012 Jan-Feb;17(1):118-24. doi: 10.3109/10837450.2010.529145. Epub 2010 Oct 26.
5
Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery.用于左氧氟沙星递送的喷雾干燥壳聚糖微球的制备及其体外释放
J Control Release. 2011 Nov 30;152 Suppl 1:e70-1. doi: 10.1016/j.jconrel.2011.08.129.
6
Synthesis and characterization of a novel chitosan/montmorillonite/hydroxyapatite nanocomposite for bone tissue engineering.用于骨组织工程的新型壳聚糖/蒙脱土/羟基磷灰石纳米复合材料的合成与表征
Biomed Mater. 2008 Sep;3(3):034122. doi: 10.1088/1748-6041/3/3/034122. Epub 2008 Sep 3.
7
Cell proliferation and controlled drug release studies of nanohybrids based on chitosan-g-lactic acid and montmorillonite.基于壳聚糖-接枝-乳酸和蒙脱石的纳米杂化物的细胞增殖及可控药物释放研究
Acta Biomater. 2009 Jan;5(1):93-100. doi: 10.1016/j.actbio.2008.08.007. Epub 2008 Aug 29.
8
Preparation and improvement of release behavior of chitosan microspheres containing insulin.含胰岛素壳聚糖微球的制备及其释放行为的改善
Int J Pharm. 2006 Mar 27;311(1-2):187-95. doi: 10.1016/j.ijpharm.2005.12.033. Epub 2006 Jan 24.
9
Preparation, characterization, and antimicrobial activity of quaternized chitosan/organic montmorillonite nanocomposites.季铵化壳聚糖/有机蒙脱土纳米复合材料的制备、表征及抗菌活性
J Biomed Mater Res A. 2008 Feb;84(2):384-90. doi: 10.1002/jbm.a.31326.
10
FT-IR study of montmorillonite-chitosan nanocomposite materials.FT-IR 研究蒙脱石-壳聚糖纳米复合材料。
Spectrochim Acta A Mol Biomol Spectrosc. 2011 Aug 15;79(4):784-8. doi: 10.1016/j.saa.2010.08.053. Epub 2010 Sep 22.

引用本文的文献

1
Preparation of Montmorillonite-Melamine Cyanurate and Inhibition of the Emission of Phosphine from PA6/Aluminum Hypophosphate.蒙脱石-三聚氰胺氰尿酸盐的制备及对PA6/次磷酸铝体系中磷化氢释放的抑制作用
Polymers (Basel). 2024 Oct 21;16(20):2946. doi: 10.3390/polym16202946.
2
Curcumin encapsulated dual cross linked sodium alginate/montmorillonite polymeric composite beads for controlled drug delivery.用于控释给药的姜黄素包封双交联海藻酸钠/蒙脱石聚合物复合珠
J Pharm Anal. 2021 Apr;11(2):191-199. doi: 10.1016/j.jpha.2020.07.002. Epub 2020 Aug 4.
3
Application of montmorillonite in bentonite as a pharmaceutical excipient in drug delivery systems.
蒙脱石在膨润土中的应用作为药物递送系统中的药用辅料。
J Pharm Investig. 2016;46(4):363-375. doi: 10.1007/s40005-016-0258-8. Epub 2016 May 21.